chevron_leftBack
As of 24 April 2025, Medpace Holdings, Inc. has a market cap of $8.34B USD, ranking #1951 globally and #682 in the United States. It ranks #170 in the Healthcare sector, and #20 in the Diagnostics & Research industry.
Key Stats
Market Cap
$8.34BUSD
Enterprise Value
$8.05BUSD
Revenue (TTM)
$2.16BUSD
EBITDA (TTM)
$485.51MUSD
Net Income (TTM)
$416.39MUSD
EBITDA Margin
23%
Profit Margin
19%
PE Ratio
22.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
August Troendle
open_in_new
Employees
5,900
Founded
1992
IPO
11 Aug 2016
Website
medpace.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.9% | -2% | -10% | -16% | -11% | -23% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MEDP
Medpace Holdings Inc
ISIN: US58506Q1094
Shares Out.:
Shares Outstanding:
30.228M1
Shares Float:
24.482M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
290.54 USD | |
|
MEDP
Medpace Holdings Inc
ISIN: US58506Q1094
|
5.87K MXN |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
